["<cs> my lords will the noble lord be good enough to reconsider the answer that he gave to my noble friend lord sainsbury when he indicated that brand names could not be kept off new products because it was a matter for the drug manufacturers <e> <s> is it not the case that the drug manufacturers lend a very careful ear to what the government have to say to them having regard to the fact that the government are their main customer <e> <s> therefore so far as new products are concerned would it not be reasonable to expect that progress could be made in this difficult matter by paying attention to what my noble friend as chairman of the committee reported <e>"]